Background Assessing the risk of intracranial hemorrhage (ICH) in patients with a mild
traumatic brain injury (MTBI) who are taking direct oral anticoagulants (DOACs) is …

Background The established clinical risk factors for post-traumatic intracranial bleeding have
not been evaluated in patients receiving DOACs yet. Aim Evaluating the association …

Background The use of anticoagulant medications leads to a higher risk of developing
traumatic intracranial hemorrhage (tICH) after a mild traumatic brain injury (mTBI). The …

Currently, all patients, regardless of the type of head injury, should undergo a head
computerized tomography (CT) if on oral anticoagulant therapy. The aim of the study was to …

Background Traumatic brain injury (TBI) is one of the leading causes of disability and death
worldwide. Most TBI cases occur in older people, because they are at a higher risk of …

Background The risk of intracranial hemorrhage (ICH) in patients taking direct oral
anticoagulants (DOACs) after mild traumatic brain injury (MTBI) is unclear. Objectives To …

Background Although the preliminary evidence seems to confirm a lower incidence of post-
traumatic bleeding in patients treated with direct oral anticoagulants (DOACs) compared to …

Prognosis after mild traumatic brain injury (MTBI) on oral anticoagulant therapy (OAT) is
uncertain. We evaluated the rate of immediate and delayed traumatic intracranial …

Background Patients taking direct oral anticoagulants (DOACs) commonly undergo CT head
imaging after minor head injury, regardless of symptoms or signs. However, the risk of …

Background The presence of oral anticoagulant therapy (OAT) alone, regardless of patient
condition, is an indication for CT imaging in patients with mild traumatic brain injury (MTBI) …